Effect of lung water content, manipulated by intratracheal furosemide, surfactant, or a mixture of both, on compliance and viscoelastic tissue forces in lung-lavaged newborn piglets

Critical Care Medicine

Volumn 28, Issue 6, 2000, Pages 1911-1917

  Flemmer, Andreas ^a   Simbruner, Georg ^a   Muenzer, Stefan ^a   Proquitté, Hans ^a   Haberl, Caroline ^a   Nicolai, Thomas ^a   Leiderer, Rosemarie ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Administration; Animal; Furosemide; Intratracheal; Lung mechanics; Lung water; Respiratory distress syndrome; Stress adaptation; Surfactant; Topical

Indexed keywords

FUROSEMIDE; LUNG SURFACTANT EXTRACT;

ADAPTATION; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TISSUE LEVEL; LUNG COMPLIANCE; LUNG FLUID; LUNG LAVAGE; LUNG MECHANICS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; STRESS; SWINE; VISCOELASTICITY;

EID: 0033945049     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200006000-00038     Document Type: Article

References (41)

1. 1. Farrell PM, Avery MA: Hyaline membrane disease. Am Rev Respir Dis 1975; 111: 657-688
2. 2. Kollef MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37
3. 3. Jobe AH: Pulmonary surfactant therapy. N Engl J Med 1993; 328:861-868
4. 4. deWinter JP, Merth IT, vanBel F, et al: Changes of respiratory system mechanics in ventilated lungs of preterm infants with two different schedules of surfactant treatment. Pediatr Res 1994; 35:541-549
5. 5. Goldsmith LS, Greenspan JS, Rubinstein SD, et al: Immediate improvement in lung volume after exogenous surfactant: Alveolar recruitment versus increased distention. J Pediatr 1991; 119:424-428
6. 6. Couser RJ, Ferrara TB, Ebert J, et al: Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. J Pediatr 1990; 116:119-124
7. 7. Walters DV: The role of pulmonary surfactant in transepithelial movement of liquid. In: Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Robertson B, Van Golde LMB, Batenburg JJ (Eds). Amsterdam, Elsevier, 1992, pp 193-213
8. 8. DeSa DJ: Pulmonary fluid content in infants with respiratory distress. J Pathol 1969; 97: 469-479
9. 9. Carlton DP, Cho SC, Davis P, et al: Surfactant treatment at birth reduces lung vascular injury and edema in preterm lambs. Pediatr Res 1995; 37:265-270
10. 10. Jobe A, Ikegami M, Jacobs H, et al: Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J Appl Physiol 1983; 55:169-176
11. 11. Bland RD, Carlton DP, Scheerer RG, et al: Lung fluid balance in lambs before and after premature birth. J Clin Invest 1989; 84: 568-576
12. 12. DeSa DJ: Respiratory distress accompanied by changes in the pulmonary water content and alveolar lining layer in newborn rabbits recovering from oxygen lack. Biol Neonat 1968; 13:271-280
13. 13. Adams FH, Yanagisawa M, Kuzela D, et al: The disappearance of fetal lung fluid following birth. J Pediatr 1971; 78:837-843
14. 14. Cook CD, Mead J, Schreiner GL, et al: Pulmonary mechanics during induced pulmonary edema in anesthetized dogs. J Appl Physiol 1959; 14:177-186
15. 15. Arnsby DH, Bellon G, Carlisle K, et al: Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant. Pediatr Pulmonol 1992; 14: 206-213
16. 16. Pérez Fontán JJ: Effect of lung lavage on stress relaxation of the respiratory system. J Appl Physiol 1989; 67:2408-2419
17. 17. Freezer NJ, Sly PD: Predictive values of measurements of respiratory mechanics in preterm infants with HMD. Pediatr Pulmonol 1993; 16:116-123
18. 18. Bachofen H, Schurch S, Urbinelli M, et al: Relations among alveolar surface tension, surface area, volume and recoil pressure. J Appl Physiol 1987; 66:1878-1887
19. 19. Fredberg JJ, Stamenovic D: On the imperfect elasticity of lung tissue. J Appl Physiol 1989; 67:2408-2419
20. 20. Heldt GP: The mechanics of breathing: Developmental aspects and practical applications. In: Boynton BR, Carlo WA, Jobe AH (Eds). New Therapies for Neonatal Respiratory Failure: A Physiological Approach. Cambridge, Cambridge University Press, 1994, pp 95-100
21. 21. Hallman M: The severity of RDS during the first two neonatal days in relationship to fluid intake. Acta Pediatr Scand 1989; 360: 93-100
22. 22. Hallman M, Merrit TA, Bry K, et al: Association between neonatal care practices and efficacy of exogenous human surfactant. Pediatrics 1993; 91:552-560
23. 23. VanMarter LJ, Pagano M, Allred EN, et al: Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practise. J Pediatr 1992; 120:938-946
24. 24. Heaf DP, Belik JB, Spitzer AR, et al: Changes in pulmonary function during the diuretic phase of respiratory distress syndrome. J Pediatr 1982; 101:103-107
25. 25. Yeh TF, Shibil A, Leu ST, et al: Early furosemide therapy in premature infants with respiratory distress syndrome: A randomized controlled trial. J Pediatr 1984; 105:603-609
26. 26. Najak ZD, Harris EM, Lazzara A Jr, et al: Pulmonary effects of furosemide in preterm infants with lung disease. J Pediatr 1983; 102:758-763
27. 27. Sladen A, Laver MB, Pontoppidan H: Pulmonary complications and water retention in prolonged mechanical vetilation. N Engl J Med 1968; 279:448-453
28. 28. Engelhardt B, Elliott S, Hazinski TA: Short and long term effects of furosemide on lung function in infants with bronchopulmonary dysplasia. J Pediatr 1986; 109:1034-1039
29. 29. Aufricht C, Votava F, Marx M, et al: Intratracheal furosemide in infants after cardiac surgery: Its effects on lung mechanics and urinary output, and its levels in plasma and tracheal aspirate. Intensive Care Med 1997; 23:992-997
30. 30. Prabhu VG, Keszler M, Dahnireddy R: Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants. Arch Dis Child 1997; 77: F32-F35
31. 31. Kugelman A, Durand M, Garg M: Pulmonary effect of inhaled furosemide in ventilated infants with severe brochopulmonary dysplasia. Pediatrics 1997; 99:71-75
32. 32. Bland RD, Nielson DW: Developmental changes in lung epithelial ion transport and liquid movement. Annu Rev Physiol 1992; 54:373-394
33. 33. Ramsden CA, Markiewicz M, Walters DV, et al: Liquid flow across the epithelium of artificially perfused lung of fetal and postnatal sheep. J Physiol Lond 1992; 448:579-597
34. 34. Fajardo C, Levin D, Garcia M, et al: Surfactant versus saline as a vehicle for corticosteroid delivery to the lungs of ventilated rabbits. Pediatr Res 1998; 43:542-547
35. 35. Sly PD, Lantreri CJ, Nicolai T: Measurement of respiratory function in the intensive care unnit. In: Stocks J, Sly P, Tepper RS, et al (Eds). Infant Respiratory Function Testing. New York, Wiley-Liss, 1996, pp 445-484
36. 36. Sly PD, Bates JHT: Computer analysis of physical factors affecting the use of the interrupter technique in infants. Pediatr Pulmonol 1988; 4:219-224
37. 37. Kobayashi T, Nitta K, Ganzuka M, et al: Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 1991; 29: 353-356
38. 38. Lachmann B, Eijking EP, So KL, et al: In vivo evaluation of inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 1994; 20:6-11
39. 39. Kelly E, Bryan H, Possmayer F, et al: Compliance of the respiratory system in newborn infants pre- and postsurfactant replacement therapy. Pediatr Pulmonol 1993; 15:225-230
40. 40. O'Donavan BH, Bell EF: Effects of furosemide on body water compartents in infants with bronchopulmonary dysplasia. Pediatr Res 1989; 26:121-124
41. 41. Bianco S, Pieroni MG, Refini RM, et al: Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N Engl J Med 1989; 321:1069-1073